A GPCR-G protein-β-arrestin megacomplex enabled by a versatile allosteric modulator
Cell · 2026-03 · 189 (5) · 1434-1450.e22
DOI: 10.1016/j.cell.2025.12.023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2026-03. Verfasst von Guodong He und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Membrane Biology, Tsinghua-Peking Center for Life Sciences, School of Pharmaceutical Sciences, Tsinghua University, Beijing, …. Hauptthemen laut MEDLINE: beta-Arrestins, Receptors, G-Protein-Coupled, GTP-Binding Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Tsinghua University.
Abstract (Originalsprache)
Approximately one-third of clinical drugs mediate their therapeutic effects through G protein-coupled receptors (GPCRs), highlighting their immense therapeutic relevance. Novel approaches to modulate GPCR activity have the potential to yield unique pharmacological profiles. Conventionally, the G protein and β-arrestin signaling pathways downstream of GPCRs have been viewed as mutually exclusive. Using the in-house developed survival pressure selection (SPS) method, a high-throughput platform for GPCR agonist discovery, we identified an allosteric ligand that stabilizes a GPCR-G protein-β-arrestin megacomplex, thereby mediating sustained receptor signaling following internalization. Remarkably, this compound, atazanavir, exhibits pan-receptor activation across multiple family A GPCRs, including GPR119, β1AR, and β2AR, demonstrating the broad applicability of this regulatory mechanism. This discovery uncovers a distinct mechanism of GPCR regulation, opening alternative avenues for the development of therapeutics targeting GPCRs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Membrane Biology, Tsinghua-Peking Center for Life Sciences, School of Pharmaceutical Sciences, Tsinghua University, Beijing, China; Beijing Frontier Research Center for Biological Structure, Beij…
- Beijing Frontier Research Center for Biological Structure, Beijing Advanced Innovation Center for Structural Biology, Tsinghua University, Beijing, China; State Key Laboratory of Membrane Biology, Tsinghua-Peking Center…
- School of Pharmacy, Changzhou University, Changzhou, China.
- Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, China.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Tsinghua University
- Center for Life Sciences
- Beijing Frontier Research Center for Biological Structure, Tsinghua University
Zitieren
APA
He, G., Sun, Q., Xu, X., Kong, F., Zhang, S., Ye, K., Sun, X., Lin, B., Chen, X., Yan, C., & Liu, X. (2026). A GPCR-G protein-β-arrestin megacomplex enabled by a versatile allosteric modulator. Cell, 189(5), 1434-1450.e22. https://doi.org/10.1016/j.cell.2025.12.023
Vancouver
He G, Sun Q, Xu X, Kong F, Zhang S, Ye K, et al. A GPCR-G protein-β-arrestin megacomplex enabled by a versatile allosteric modulator. Cell. 2026;189(5):1434-1450.e22. doi:10.1016/j.cell.2025.12.023
BibTeX
@article{He2026,
author = {He, Guodong and Sun, Qinxin and Xu, Xinyu and Kong, Fang and Zhang, Shuhao and Ye, Kexin and Sun, Xiaoou and Lin, Bin and Chen, Xin and Yan, Chuangye and Liu, Xiangyu},
title = {A GPCR-G protein-β-arrestin megacomplex enabled by a versatile allosteric modulator},
journal = {Cell},
year = {2026},
volume = {189},
number = {5},
pages = {1434--1450.e22},
doi = {10.1016/j.cell.2025.12.023}
}
EUVIMED